Literature DB >> 14697891

The effect of diabetes mellitus on the morphology and physiology of monoamine oxidase in the pancreas.

Ernest Adeghate1, Hasan Parvez.   

Abstract

Monoamine oxidase (MAO) is an ubiquitous, non-soluble, membrane-bound enzyme, located in the outer membrane of mitochondria. MAO consists of two subtypes, MAO-A and MAO-B, depending on their substrates and sensitivity to inhibitors. MAO consists of two units joined together by a disulphide bond. The two units of MAO and flavin adenine dinucleotide (FAD) form a polymer in the outer membrane of mitochondria. The function of MAO-A is highly dependent on the lipid constituent of mitochondrial membrane, whereas the function of MAO-B does not depend on the lipid status of mitochondrial membrane. Hydrogen peroxide and ammonia are generated during MAO-induced metabolism of its substrates. MAO and its substrates are present in both the exocrine as well as the endocrine parts of the pancreas. In the islet of Langerhans, MAO-A is observed in about 50% of the cells, whereas MAO-B is less abundant and located mainly in the periphery of pancreatic islets. MAO-B is also demonstrated in centroacinar cells and in pancreatic ducts. Electron microscopy studies suggest that MAO is co-localised with insulin in secretory granules of pancreatic beta cells. Pharmacologically, beta-2-adrenoreceptors agonists such as terbutaline can stimulate MAO activity. In contrast, cholinergic muscarinic stimulation does not affect islet MAO activity. MAO activity in pancreatic tissue is significantly reduced in diabetes. This decrease in MAO activity is associated with an increase in pancreatic tissue levels of adrenaline (ADR) and noradrenaline (NA). Studies on the level of 5-hydroxyindoleacetic acid of pancreatic tissues suggest that serotonin level is also increased in diabetics. Many studies show that MAO inhibits insulin secretion. However, some of its substrates including, serotonin, adrenaline and noradrenaline have been shown to stimulate insulin secretion. In conclusion, the activity and subcellular localisation of MAO suggests that MAO may play an important role in pancreatic beta cell function and hence in the pathogenesis of diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14697891     DOI: 10.1016/S0161-813X(03)00091-3

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  7 in total

1.  Tryptamine induces tryptophanyl-tRNA synthetase-mediated neurodegeneration with neurofibrillary tangles in human cell and mouse models.

Authors:  Elena L Paley; Galina Denisova; Olga Sokolova; Natalia Posternak; Xukui Wang; Anna-Liisa Brownell
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

Review 2.  Translational neuroimaging: positron emission tomography studies of monoamine oxidase.

Authors:  Joanna S Fowler; Jean Logan; Nora D Volkow; Gene-Jack Wang
Journal:  Mol Imaging Biol       Date:  2005 Nov-Dec       Impact factor: 3.488

3.  Regulation of monoamine oxidase A (MAO-A) expression, activity, and function in IL-13-stimulated monocytes and A549 lung carcinoma cells.

Authors:  Sukhamoy Dhabal; Pradip Das; Pritam Biswas; Priyanka Kumari; Valentin P Yakubenko; Suman Kundu; Martha K Cathcart; Manjari Kundu; Kaushik Biswas; Ashish Bhattacharjee
Journal:  J Biol Chem       Date:  2018-07-18       Impact factor: 5.157

4.  Monoamine oxidase A (MAO-A): a signature marker of alternatively activated monocytes/macrophages.

Authors:  Martha K Cathcart; Ashish Bhattacharjee
Journal:  Inflamm Cell Signal       Date:  2014

5.  6-[18F]fluoro-L-DOPA uptake in the rat pancreas is dependent on the tracer metabolism.

Authors:  Teemu Kalliokoski; Johanna Tuomela; Laura Haavisto; Sarita Forsback; Anniina Snellman; Semi Helin; Tove J Grönroos; Olof Solin; Merja Haaparanta-Solin
Journal:  Mol Imaging Biol       Date:  2013-11-12       Impact factor: 3.488

6.  The effect of l-deprenyl on tissue mRNA expressions of NOS isoforms and NO levels in an experimental diabetes mellitus model.

Authors:  S V Irer; G Ercan Alper; E D Sezer; E Duman; F Saatcioglu; C Yilmaz
Journal:  J Neural Transm (Vienna)       Date:  2007-04-20       Impact factor: 3.575

7.  MAOA promoter methylation and susceptibility to carotid atherosclerosis: role of familial factors in a monozygotic twin sample.

Authors:  Jinying Zhao; Christopher W Forsberg; Jack Goldberg; Nicholas L Smith; Viola Vaccarino
Journal:  BMC Med Genet       Date:  2012-11-02       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.